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A B S T R A C T
Introduction. Inflammatory bowel disease (IBD) is likely to have an impact on sexual function because of its
symptoms, like diarrhea, fatigue, and abdominal pain. Depression is commonly reported in IBD and is also related
to impaired sexual function. This study aimed to evaluate sexual function and its association with depression among
patients with IBD compared with controls.
Methods. IBD patients registered at two hospitals participated. The control group consisted of a general practitioner
practice population. The web-based questionnaire included the Female Sexual Function Index (FSFI) for women and
the International Index of Erectile Function (IIEF) for men. Other variables evaluated were depression, disease
activity, IBD-related quality of life, body image, and fatigue.
Results. In total, 168 female and 119 male patients were available for analysis (response rate 24%). Overall, patients
with IBD did not significantly differ in prevalence of sexual dysfunctions from controls: female patients 52%, female
controls 44%, male patients and male controls both 25%. However, men and women with an active disease scored
significantly lower than patients in remission and controls, indicating impaired sexual functioning during disease
activity. Significant associations were found between active disease, fatigue, depressive mood, quality of life, and
sexual function for both male and female patients. The association between disease activity and sexual function was
totally mediated by depression.
Conclusion. Male and female IBD patients with an active disease show impaired sexual function relative to
patients in remission and controls. Depression is the most important determinant for impaired sexual function in
IBD. Bel LGJ, Vollebregt AM, Van der Meulen-de Jong AE, Fidder HH, Ten Hove WR, Vliet-Vlieland
CW, ter Kuile MM, de Groot HE and Both S. Sexual dysfunctions in men and women with inflammatory
bowel disease. The influence of IBD-related clinical factors and depression on sexual function. J Sex Med
2015;12:1557–1567.
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Introduction
I nflammatory Bowel Diseases (IBD), Crohn’sdisease (CD) and ulcerative colitis (UC), are
characterized by a chronically relapsing course
[1,2]. Because of symptoms like abdominal pain,
fatigue, bloating, gas, and diarrhea, IBD is likely to
have a substantial impact on body image, intimacy
and sexuality [1,2]. Complications may include
perianal disease, fistulae and abscesses. Surgery is
frequently necessary, sometimes including the
placement of a stoma or pouch. Furthermore,
mood disorders, mainly depression, are reported
to be common in IBD [3]. As sexual dysfunction is
also known to be related to depression [4–9],
depression may be an important determinant of
sexual functioning in patients with IBD.
Studies about sexual functioning in IBD patients
are scarce. Muller et al. [10] reported that 66.8% of
the IBD patients felt that their body image was
impaired due to the IBD. Timmer et al. [11] studied
a male sample with IBD from a clinic and from a
patients’ organization group and compared them
with general population means. She reported no
differences on the International Index of Erectile
Function (IIEF), compared with the general popu-
lation, all scores were below the standard mean, but
within 1 standard deviation (SD) for both groups.
But both disease activity and depressive mood were
associated with diminished sexual function. Moody
et al. [12] reported that female patients with CD
had significantly more dyspareunia and more often
no sexual intercourse than age-matched controls.
However, in a later study, Moody and Mayberry
[13] reported no differences in the frequency of
sexual intercourse between male patients with IBD
and female patients with UC compared with con-
trols. Timmer et al. [14] reported no differences
between female patients with IBD and controls on
the Brief Index of Sexual Function in Women, but
female patients with an active disease felt less
attractive and less feminine than patients in remis-
sion. In another study done by Timmer et al. [15]
depression was the most important determinant of
impaired sexual function for both male and female
patients. Taken together, the knowledge about
sexual dysfunctions in patients with IBD is limited,
and so far, the studies have shown mixed results.
However, the study results indicate that active
disease is associated with impaired sexual function
and that in particular, depression may be an impor-
tant mediator of this association. We aimed to
evaluate the prevalence of sexual dysfunctions in
men and women with IBD, compared with the
prevalence in an age-matched control group. Fur-
thermore, we evaluated in patients the associations
of disease activity, IBD-related quality of life, body
image, fatigue and depression with sexual function,
and tested whether quality of life, body image,
fatigue, and depression were mediating variables in
the association between active IBD and impaired
sexual function. It was expected that: (i) patient with
IBD would report more sexual problems than
healthy controls; (ii) patients with active disease
would report more sexual problems than patients in
remission; and (iii) that in particular depression
would mediate the association between active IBD
and impaired sexual function.
Materials and Methods
Setting and Sample
All patients registered in 2011 with CD or UC at
the Gastroenterology departments of a tertiary
referral center (Leiden University Medical Center)
and a general hospital (Diaconessenhuis Leiden) in
the Netherlands were invited to participate by
regular mail. Patients were eligible for inclusion if
they were 18–70 years of age, diagnosed with CD or
UC, and had a stable heterosexual relationship for
at least 3 months. The patients received written
information about the study at their home address.
In this information letter, patients were informed
about the purpose and procedure of the study.
Based on the written information, the patient could
decide to fill in the web-based questionnaire or fill
in that he/she was not interested to participate. All
patients who did not return the questionnaire
within 3 weeks received a reminder by regular mail.
An age-matched control group of healthy men and
women, registered at a general practitioner practice
in the same region as the participating hospitals,
were also invited to participate. The controls were
eligible if they were 18–70 years of age, had a stable
heterosexual relationship for at least 3 months and
did not have bowel problems, like IBD or irritable
bowel syndrome. Exclusion criteria for both
patients and controls were pregnancy and lactation.
If the questionnaire contained less than 75% of the
answers, the questionnaire was not included for
evaluation.
The study was approved by the ethics commit-
tee or the steering board of the participating
medical centers. The gastroenterologists ware
unaware which of the patients filled in the ques-
tionnaire. Only the medical researchers could
reveal the patient number to look at the Montreal
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classification in the medical records, in order to
establish the severity of disease in patients.
Instruments
Assessment of Basic Characteristics
Both patients and controls received questions about
socio-demographics. Data were collected about
date of birth, the duration of their relationship,
having children and level of education. There were
also questions about height and weight for the
calculation of the body mass index (BMI). Women
received questions about use of contraceptives,
pregnancy, lactation, and hormone suppletion.
Both patients and controls received questions about
having (other) chronic disease, use of medication
[16] and history of lower abdominal surgery.
Assessment of Sexual Function
Sexual function in men was measured using the
IIEF. The IIEF is a brief multidimensional self-
report instrument consisting of five subscales:
erectile function (five items), orgasmic function
(two items), sexual desire (two items), intercourse
satisfaction (three items), and overall satisfaction
(two items). The score can range from 5 to 75.
Higher scores indicate better sexual function. The
IIEF has a good internal reliability and is able to
differentiate well between clinical samples and
non-dysfunctional controls [17]. To define patients
with and without sexual dysfunction, in this study
a cut-off score of 42.9, 1 SD below the mean of a
healthy population [17,18] was applied. For erec-
tile dysfunction, a cut-off score of 25 on the
subscale erectile function was used [19].
Sexual function in women was assessed with the
Female Sexual Function Index (FSFI) [20]. The
FSFI is a brief multidimensional self-report instru-
ment consisting of six subscales: desire (two items),
arousal (four items), lubrication (four items),
orgasm (three items), satisfaction (three items),
and pain (three items). Total scores can range from
2 to 36. Higher scores indicate better sexual func-
tion. The FSFI has good internal reliability and is
also able to differentiate between clinical samples
and non-dysfunctional controls, using a cut-off
score of 26.55 [20–22].
Assessment of Depression and Clinical Factors
Depression was evaluated using the 14-item Hos-
pital Anxiety Depression Scale (HADS) [23]. The
HADS has a good internal reliability and good
test–retest reliability [24]. Total score for the
subscale depression range from 0 to 21. A higher
score indicates more depressive symptoms. A score
8 or above on the subscale depression, indicates
presence of clinical depression [25].
The questionnaire for the IBD patients
included disease-specific instruments and a fatigue
inventory. The Short Inflammatory Bowel Disease
Questionnaire (SIBDQ) [26] is a short disease-
specific quality of life instrument and is able to
measure clinical changes in health-related quality
of life for both CD and UC [27]. A higher score
indicates a better disease-related quality of life
[26]. Disease activity was evaluated using the
Simple Clinical Colitis Activity Index (SCCAI)
[28] for patients with UC, and the Harvey–
Bradshaw Index (HBI) [29] for patients with CD.
For both questionnaires a score of 5 or more is an
indication of an active disease [30–32].
The Multidimensional Fatigue Inventory-20
(MFI-20) [33] measured fatigue. It has a good
internal consistency [34]. A higher score indicates
more fatigue. Fatigue was defined as a general
fatigue score above the 95th percentile mean score
of healthy controls as used in the study from
Minderhoud et al. [35]. From the European
Organisation for Research and Treatment of
Cancer (EORTC) Quality of Life questionnaire
for Colorectal Cancer (EORTC-QLQ-CR38)
[36] patients received three questions about body
images (physical attractiveness, feeling masculine/
feminine, and satisfaction about his/her body). A
higher score means a less positive body image.
Although this questionnaire has been used in
research with IBD patients[11,14], it is neither
designed nor validated for this patient group.
The Montreal Classification for the classifica-
tion of CD and UC was received from the medical
records.
Procedure
Participants were given written information about the
study and gave informed consent before participation.
The data were collected using the web-based software
Netquestionnaire (NetQ Insights BV, Amsterdam,
the Netherlands). All eligible patients were numbered
consecutively. Data of each participant was entered in
a database using a number. The number and data
cannot be linked to participants. In this way, complete
privacy is guaranteed. A list with the names of the
participants, their study number, and their date of
birth, was however stored by the investigator (sepa-
rated from the collected data), as this information was
needed to link the collected data to the medical
records of the IBD patients.
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Statistical Analyses
Statistical analyses were performed using SPSS (v.
20, SPSS, Inc., Chicago, IL, USA). First, sexual
function, depression, quality of life, fatigue, and
body image scores were analyzed separately for
men and women, and for patients with active
disease versus patients in remission and controls.
Student’s t- and χ2 test were used to compare
means and to test associations, analyses of covari-
ance were used to correct for differences in base-
line characteristics. Second, Z-scores were
calculated for sexual function scores to examine
the associations between disease activity, depres-
sion, quality of life, fatigue, and body image with
sexual functioning within the male and female
patient group using bivariate correlation analyses.
Furthermore, in order to test whether quality of
life, fatigue, depression, and body image mediated
the hypothesized association between disease
activity and sexual functioning, sexual functioning
was regressed upon, respectively, quality of life,
fatigue, depression, body image, and disease activ-
ity. Relevant demographic variables were entered
as control variables. Mediation occurs if: (i) disease
activity significantly affects the mediator (IBD
quality of life, fatigue, body image and depression);
(ii) disease activity significantly affects sexual func-
tioning in the absence of the mediator; (iii) the
mediator has a significant and unique effect on
sexual functioning; and (iv) the effect of disease
activity on sexual functioning shrinks upon the
addition of the mediator into the model [37]. To
test whether putative mediators (partly) mediated
the relationship of disease activity and sexual func-
tioning, the standard error of the mediated effect
was bootstrapped [38]. The macro for SPSS devel-
oped by Preacher and Hayes was used to generate
estimates for the indirect effects in multiple
mediator models [39]. The level of significance
used was P < 0.05.
Results
Participants Basic Characteristics
In total, 1,581 patients and 1,018 controls were
requested to participate. Response rate for the
controls was 30% (n = 303) and for the patients
24% (n = 372). After age-matching, there were
168 female patients, 106 female controls, 119 male
patients, and 91 male controls available for analy-
sis. The other responders were excluded because
they did not have a relationship, had a relationship
shorter than 3 months, were pregnant or lactating,
or they answered less than 75% of the questions.
Basic characteristics of the study population are
shown in Table 1. Female patients were compa-
rable with controls on most characteristics.
However, as expected, they had undergone more
surgical procedures in the pelvis, had more sys-
temic diseases other than IBD, had more diseases,
and used more medication with possible influence
on sexual function. Male patients and controls
were comparable except for BMI with male con-
trols having a higher BMI than male patients. The
male patients were significantly older than the
female patients, t(279) = 5.27, P < 0.001.
Disease Activity and Quality of Life
The Montreal Classification and disease activity
are shown in Table 2. Male CD and UC patients
scored comparable on the SIBDQ. Of the men
with CD, 30.4% had an active disease (HBI > 5),
versus 31.7% of the men with UC (SCCAI > 5)
(P > 0.05). Women with CD scored significantly
higher on the SIBDQ as compared with women
with UC, t(161) = −2.53, P < 0.05. Of the women
with CD, 43.9% had an active disease (HBI > 5),
versus 28.4% of the women with UC (SCCAI > 5),
χ2 (1) = 4.09, P < 0.05.
Depression, Fatigue, and Body Image
Data on depression, fatigue, and body image are
shown in Table 3. Patients (men as well as women)
with an active disease had significantly more often
a score indicating a depression than patients in
remission and controls. Often, male patients in
remission had significantly less scores indicating a
depression than controls. Female patients in
remission and controls scored comparably.
Patients with active disease suffered significantly
more often from fatigue and had a significant
lower body image compared with patients in
remission. This applied to men as well as women.
Sexual Function
Overall, men and women with IBD scored com-
parable with controls on the IIEF and the FSFI
(see Tables 4 and 5). However, male patients with
active disease reported more orgasm problems and
were less satisfied compared with controls, and
reported more erectile problems, more orgasm
problems, less sexual desire, and were less satisfied
compared with patients in remission (see Table 4).
In the total group of male patients with IBD,
25.2% had a sexual dysfunction (score of <42.9)
and in the control group this was 25.3%. Of the
male patients with an active disease, 36.1% had a
sexual dysfunction, in comparison with 18.8% of
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the male patients in remission, χ2 (1) = 4.09,
P < 0.05, and 25.3% in the control group, χ2
(1) = 1.49, P > 0.05. In the total group of male
patients with IBD, 46.2% had erectile dysfunction
(score < 25) and in the control group this was
40.7%, χ2 (1) = 0.65, P > 0.05. Of the male
patients with active disease, 58.3% had erectile
dysfunction, in comparison with 40% of the male
patients in remission, χ2 (1) = 3.36, P > 0.05, and
40.7% in the control group, χ2 (1) = 3.25,
P > 0.05).
Female patients with active disease reported
more lubrication problems and more dyspareunia
compared with patients in remission and controls
(see Table 5). In the total group of women with
IBD, 51.2% had sexual dysfunction, against 44.3%
of the control group, χ2 (1) = 1.22, P > 0.05. Of the
women with an active IBD, 63.1% had sexual dys-
function (total score < 26.55), against 44% of
women in remission, χ2 (1) = 5.74, P < 0.05, and
44.3% of the control group, χ2 (1) = 5.66, P < 0.05.
Associations with Sexual Functioning in Patients
Table 6 reports correlations between sexual func-
tion, age, relationship duration, gender, disease
activity, and the putative mediating factors, quality
of life, fatigue, depression, and body image. Age
and relationship duration were significantly corre-
lated with sexual function. Patients with higher age
and longer relationship duration reported more
sexual problems. Also, as expected, disease activity
was significantly associated with sexual function.
Patients with more active disease reported more
sexual problems. The putative mediating variables
quality of life, fatigue, depression, and body image
were all significantly correlated with sexual func-
tioning. Patients reporting higher quality of life
reported less sexual problems, and patients scoring
higher on fatigue, depression, and negative body
image reported more sexual problems.
Mediators of the Association of Disease Activity with
Sexual Function
In order to test whether quality of life, fatigue,
depression, and body image mediated the associa-
tion between disease activity and sexual function-
ing, sexual functioning was regressed upon,
respectively, quality of life, fatigue, depression,
body image, and disease activity. In each of these
mediation analyses, gender, age, and relationship
duration were entered as control variables. In the
mediation analysis with gender, age, relationship
duration, quality of life, and disease activity being
included together in the regression equation,












N = 91 P value
Age (years)* 42.9 (12.9) 43.8 (12.8) 0.58 51.1 (12.8) 52.4 (12.7) 0.47
BMI (kg/m2) 21.0 (4.5) 20.8 (3.2) 0.71 23.0 (3.1) 24.0 (3.4) 0.03
Relationship duration (years) 17.2 (13.5) 18.1 (14.0) 0.59 23.2 (14.3) 24.6 (15.0) 0.47
Children (yes) 97 (57.7%) 72 (68.6%) 0.07 94 (79.0%) 81 (89%) 0.05
Education 0.66 0.58
Basic level 20 (11.9%) 16 (15.1%) 13 (10.9%) 14 (15.4%)
Medium level 89 (53.0%) 57 (53.8%) 53 (44.5%) 36 (39.6%)
High level 59 (35.1%) 33 (31.1%) 53 (44.5%) 41 (45.1%)
Hormonal contraception (yes) 64 (38.1%) 43 (40.6%) 0.68
Estrogen medication (yes) 4 (2.4%) 6 (5.7%) 0.16
Operations in pelvis (yes)† 68 (40.5%) 2 (1.9%) 0.000 48 (40.3%) 31 (34.1%) 0.35
Medication with possible influence on sexual function‡ 0.000 0.24
None 106 (63.1%) 96 (90.6%) 71 (59.7%) 64 (70.3%)
Minor 38 (22.6%) 10 (9.4%) 25 (21.0%) 16 (17.6%)
Major 24 (14.3%) 0 (0.0%) 23 (19.3%) 41 (45.1%)
Systemic disease 0.000 0.18
None 128 (76.2%) 102 (96.2%) 102 (85.7%) 74 (81.3%)
Minor 31 (19.0%) 4 (3.8%) 11 (9.2%) 15 (16.5%)
Major 8 (4.8%) 0 (0.0%) 6 (5.0%) 11 (12.1%)
Disease with possible influence on sexual function§ (yes) 15 (8.9%) 1 (0.9%) 0.006 10 (8.4%) 9 (9.9%) 0.71
*M (SD).
†Ten of the male controls underwent vasectomy.
‡Antihypertensive medication, antidepressants, antiepileptics, antipsychotics, benzodiazepines, statins, antacids, digoxin, and corticosteroids. Minor = 1,
major = ≥2.
§Female patients: MS N = 1, hypo/hyperthyroid N = 5, DM type II N = 1, COPD N = 1, renal insufficiency N = 1, hypertension N = 4, Morbus Sheehan N = 1,
depression N = 1. Female controls: MS N = 1. Male patients: Parkinson N = 1, heart disease N = 5, DM type II N = 5, COPD N = 1. Male controls: DM type II N = 5,
hypertension N = 6.
BMI = body mass index; COPD = chronic obstructive pulmonary disease; DM = diabetes mellitus; MS = multiple sclerosis; SD = standard deviation.
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quality of life was a significant predictor, β = 0.32,
t = 4.84, P < 0.001, and the relationship between
sexual functioning and disease activity decreased in
strength, from β = −0.17, t = −2.95, P < 0.01 to
β = −0.01, t = −0.18, P = 0.86. In the mediation
analysis with gender, age, relationship duration,
fatigue, and disease activity being included
together in the regression equation, fatigue
was a significant predictor, β = 0.33, t = −5,61,
P < 0.001, and the relationship between sexual
functioning and disease activity decreased in
strength, from β = −0.17, t = −3.03, P < 0.01 to
β = −0.04, t = −0.61, P = 0.54. Similarly, in the
mediation analysis with gender, age, relationship
duration, depression, and disease activity being
included together in the regression equation,
Table 2 Montreal Classification and disease activity
Montreal classification
Crohn’s disease Ulcerative colitis
Men Women Men Women
N = 57 N = 98 N = 62 N = 70*
Age at diagnosis (years)
A1 (<17) 5 (8.8%) 7 (7.1%)
A2 (17–40) 42 (73.7%) 78 (79.6%)
A3 (>40) 10 (17.5%) 13 (13.3%)
Location
L1 (ileal) 19 (33.3%) 18 (18.4%)
L2 (colonic) 7 (12.3%) 22 (22.4%)
L3 (ileocolonic) 31 (54.5%) 58 (59.2%)
+L4 (upper digestive) 9 (15.8%) 4 (4.1%)
+P (perianal disease modifier) 20 (35.1%) 31 (31.6%)
Behavior
B1 (non-stricturing, non-penetrating) 23 (40.4%) 52 (53.1%)
B2 (stricturing) 13 (22.8%) 18 (18.4%)
B3 (penetrating) 10 (17.5%) 12 (12.2%)
B2 + B3 (both stricturing as penetrating) 11 (19.3%) 16 (16.3%)
Extend colitis
E1 (proctitis) 6 (9.7%) 16 (22.9%)
E2 (left-sided UC) 14 (22.6%) 17 (24.3%)
E3 (wxtensive UC) 42 (67.7%) 35 (50.0%)
Disease severity
S0 (remission) 41 (66.1%) 46 (65.7%)
S1 (mild) 10 (16.1%) 8 (11.4%)
S2 (moderate) 3 (4.8%) 3 (4.3%)
S3 (severe) 0 0
Patients with a IPAA 8 (12.9%) 13 (18.6%)
Disease activity
HBI score 3.98 (2.55) 4.74 (4.01)
SCCAI score 3.30 (3.31) 3.39 (2.55)
SIBDQ score 5.50 (0.99) 4.98 (0.99) 5.72 (1.07) 5.35 (0.88)
*For two UC patients, the extent of the disease missed.
HBI = Harvey–Bradshaw Index; IPAA = ileal pouch anal anastomosis; SCCAI = Simple Clinical Colitis Activity Index; SIBDQ = Short Inflammatory Bowel Disease
Questionnaire; UC = ulcerative colitis.













Depression N (%) 17 (18.7) 15 (41.7) 4 (5) 24.37* 7.23** 7.40**
Fatigued patients N (%) 24 (66.7) 19 (23.8) 19.60*
Body image mean score (SD) 5.61 (2.31) 3.82 (1.33) −5.25*
Women
Depression N (%) 11 (10.4) 16 (25.8) 12 (11.7) 5.50*** 6.64*** 0.14
Fatigued patients N (%) 48 (73.8) 52 (52) 7.88**
Body image mean score (SD) 6.20 (2.78) 4.58 (1.68) −4.65*
*P < 0.001, **P < 0.01, ***P < 0.05.
SD = standard deviation.
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depression was a significant predictor, β = −0.35,
t = −6.26, P < 0.001, and the relationship between
sexual functioning and disease activity decreased in
strength, from β = −0.17, t = −3.03, P < 0.01 to
β = −0.04, t = −0.81, P = 0.41. And finally, in the
mediation analysis with gender, age, relationship
duration, body image, and disease activity being
included together in the regression equation, body
image was a significant predictor, β = −0.20,
t = −2.12, P < 0.001, and the relationship between
sexual functioning and disease activity decreased in
strength, from β = −0.16, t = −2.84, P < 0.01 to
β = −0.08, t = −1.46, P = 0.15. Bootstrapping the
indirect effects of these univariate mediators on
sexual functioning using 5.000 bootstrap samples,
indicated that quality of life, fatigue, depression,
and body image all significantly mediated the rela-
tionship between sexual functioning and disease
activity. When, however, as a next step, these four
mediating variables were entered together in one
Table 4 Mean International Index of Erectile Function scores (standard deviation) of patients with an active disease,











N = 36 N = 80 N = 91 t value t value t value
Erectile function 20.17 (9.63) 23.95 (8.00) 22.30 (9.95) 1.83 −2.13* −0.12
Orgasm 6.89 (3.69) 8.71 (2.73) 8.16 (3.41) 2.24* −3.09** −0.93
Sexual desire 6.11 (2.23) 7.39 (1.70) 6.86 (1.98) −1.85 3.39** 1.87
Sexual satisfaction 7.92 (4.94) 9.36 (4.47) 9.04 (5.08) 1.65 −1.80 0.01
Overall Satisfaction 6.28 (2.49) 7.54 (2.09) 7.47 (2.41) −2.49* 2.83** 0.19
Total score 47.36 (20.60) 56.95 (16.69) 53.84 (20.39) 2.04* −2.59* −0.40
*P < 0.05, ** P < 0.01
†Active disease meant a Simple Clinical Colitis Activity Index total score or a HBI total score ≥5















N = 65 N = 100 N = 106 t-value t-value t-value
Desire 3.03 (1.16) 3.09 (1.18) 3.19 (1.24) −0.87 0.33 −0.61
Arousal 3.50 (1.96) 3.82 (1.88) 3.95 (1.78) −1.54 1.04 −0.52
Lubrication 3.77 (2.15) 4.32 (2.21) 4.51 (2.20) 2.64** −2.10* 0.48
Orgasm 3.71 (2.20) 4.08 (2.14) 4.17 (2.07) 1.54 −1.33 0.17
Satisfaction 4.14 (1.66) 4.46 (1.57) 4.41 (1.58) 0.89 −1.17 −0.34
Pain 3.25 (2.44) 4.39 (2.32) 4.33 (2.38) 3.33** −3.48** −0.22
Total score 21.39 (10.04) 24.16 (10.20) 24.34 (10.15) 2.30* −2.13* 0.20
*P < 0.05, ** P < 0.01.
†Active disease meant a Simple Clinical Colitis Activity Index total score or a Harvey–Bradshaw Index total score ≥5. For one control, the lubrication score missed,
and for eight controls, the satisfaction score





of life Fatigue Depression
Body
image
Age −0.31** 0.21** −0.05 −0.01 −0.18**
Gender −0.03 −0.24** 0.15* 0.02 −0.18**
Relationship duration −0.29** 0.21** −0.09 −0.01 −0.18**
Disease activity −0.18** −0.51** 0.43** 0.36** 0.38**
Quality of life 0.25** — −0.34** −0.63** −0.67**
Fatigue −0.34** −0.76** — 0.69** 0.55**
Depression −0.37** −0.63** 0.69** — 0.54**
Body image −0.19** −0.67** 0.55** 0.54** —
N varies from 274 to 281, *P < 0.05, **P < 0.01
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model, depression appeared as the only significant
mediator (see Table 7). In fact, the model with
gender, age, relationships, and depression entered
explained an equal amount of variance, R2 = 0.25,
F(5,277) = 18.17, P < 0.001, compared with the
model with the control variables and quality of life,
fatigue, depression, and body image entered,
R2 = 0.25, F(8,273) = 11.25, P < 0.001. Bootstrap-
ping the indirect effects of depression on sexual
functioning using 5.000 bootstrap samples,
depression proved to be a significant mediator of
disease activity in sexual functioning, while con-
trolling for gender, age, and relationship duration.
The results indicate that the differences in sexual
functioning between patients with and without
active disease were totally mediated by depression.
Discussion
The present study does not show a higher preva-
lence of sexual dysfunction in patients with IBD
compared with controls. However, significantly
more male and female patients with active IBD
scored within the sexual dysfunctional range
compared with patients in remission or healthy
controls. More male patients with active disease
had a sexual dysfunction, in comparison with
male patients in remission. Male patients with
active disease scored lower on orgasm and overall
sexual satisfaction compared with controls, and
scored lower on erectile function, orgasm, desire,
and sexual satisfaction compared with patients in
remission. More female patients with active
disease had a sexual dysfunction compared with
patients in remission and controls. Female
patients with active disease scored lower on the
FSFI lubrication and pain domains compared
with patients in remission and controls, indicat-
ing more problems with lubrication and pain
during intercourse. The association of disease
activity and sexual function was totally mediated
by depression.
In our IBD patient group (both CD and UC), a
relatively high percentage of patients had active
disease (31% of the men and 39% of the women).
Other studies reported comparable percentages of
patients with active disease (26% of the men and
35% of the women) [11,14]. The response rates in
the tertiary referral center and general hospital
were 26% and 20%.
Our findings support the results reported in
other studies. Timmer et al. [11] reported that
disease activity had a significant influence on
sexual functioning. The greatest influence was
found on the subscales orgasm and sexual desire. It
was also previously reported that male patients in
remission scored comparably on the IIEF as con-
trols [15]. Moody reported more dyspareunia in
female CD patients, which is in accordance with
our study, in which we found that women with an
active disease reported more complaints of pain
during intercourse [5].
In agreement with the results of studies from
Timmer et al. [11,14,15], we found that depressive
symptoms are strongly associated with sexual dys-
function. Depression was even the only factor that
significantly mediated the association between
disease activity and sexual function. Although
patients with active disease reported, apart from
higher levels of depressive mood, also higher levels
of fatigue, lower disease-related quality of life, and
a more negative body image, and these variables
were all associated with worse sexual functioning,
the effect of active disease on sexual functioning
was mediated only by depression. This indicates
that active IBD impacts sexual functioning mainly
through the impact of active disease on mood,
corroborating with other studies pointing to an
important role of depression in the negative effects
of chronic somatic disease on sexual functioning
[5,40,41]. Depression may possibly, through the
effect of negative thinking, influence the percep-
Table 7 Regression models with only control variables
included, control variables plus disease activity included,
and control variables, disease activity, plus putative
mediating variables included
Predictor Beta t-value P value
Model 1
Constant 2.28 0.023
Gender 0.13 2.10 0.036
Relationship duration −0.09 −0.99 0.324
Age −0.25 −2.44 0.015
Model 2
Constant 2.68 0.008
Gender 0.12 1.93 0.055
Relationship duration −0.13 −1.28 0.201
Age −0.22 −2.20 0.028
Disease activity −0.16 −2.84 0.005
Model 3
Constant 1.32 0.189
Gender 0.09 1.56 0.119
Relationship duration −0.13 −1.35 0.179
Age −0.25 −2.57 0.011
Disease activity 0.01 0.06 0.950
Quality of life 0.02 0.71 0.476
Fatigue −0.15 −1.65 0.101
Depression 0.07 −3.00 0.003
Body image −0.23 0.32 0.747
Total model 1 R2 = 0.10, F(3,270) = 10,34, P < 0.001; total model 2 R2 = 0.13,
F(4,269) = 9.97, P < 0.001; total model 3 R2 = 0.25, F(8,265) = 11.25,
P < 0.001.
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tion and also reporting of sexual functioning.
However, it likely affects sexual functioning via
various cognitive, neurobiological, interpersonal,
and intrapersonal mechanisms, which are to date
largely unknown.
Regarding depressive symptoms, we observed a
difference in the prevalence of depression between
IBD patients with active disease and controls,
which is similar to a review from 2009, where
depression was more often found in IBD patients
than in controls [1]. This review discussed
population-based studies as well as studies com-
paring clinical samples with controls, and there
was no statement made about the severity of the
disease.
Regarding fatigue, our results are in agreement
with the study by Minderhoud et al. [35], who also
found significant differences with the MFI-20
between patients with an active disease and
patients in remission. And Jelsness-Jorgensen [42]
reported that half of the patients with IBD expe-
rienced substantial fatigue, measured with the
Fatigue Questionnaire (FQ). Taken together, it
seems that more patients with active IBD suffer
from fatigue, are depressed, and have sexual prob-
lems. Unfortunately the FQ was not presented to
the control population, so it is difficult to draw
conclusions about the extent of fatigue in compari-
son with a general population. As patients in
remission score comparable with—or even better
than—controls on depression and sexual function,
it is likely that the emotional and sexual problems
patients experience while their disease is active
decrease when disease activity decreases. Strik-
ingly, the data indicate that in men, mood and
sexual functioning are even better in patients in
remission compared with healthy controls. Possi-
bly male patients in remission compare their mood
and sexual functioning with their mood and sexual
functioning during active disease and perceive
their functioning more positive because of a con-
trast effect. Another explanation may be that male
patients in remission take advantage of their better
physical condition, by employing more pleasur-
able activities and sexual activities, which may
facilitate mood and sexual satisfaction.
We should discuss several limitations of our
study. One limitation is the low response rate for
both the patients and the controls. This impairs
the generalizability of the study results. Since no
information was obtained about the demographic
characteristics of the patients or controls not
willing to participate, we do not know whether
specific groups were less represented in our study
groups. It should also be noted that in our study, a
high proportion of controls reported sexual prob-
lems. A possible explanation for this high fraction
could be self-selection bias. Possibly, mainly indi-
viduals with sexual problems decided to participate
because they recognize the importance of research
on sexual functioning. However, this may also be
the case in the IBD patients. The female control
group scored 20% lower on the FSFI than the
control group in the Rosen et al. study [20]. And in
comparison with a European control group, our
female control group scored 16% lower on the
FSFI [43]. The same is for the male control group,
our control group scored 10% lower than the
control group of Rosen [17]. It cannot be ruled out
that the exceptional high percentage of our con-
trols reporting sexual problems may have obscured
a difference in prevalence of sexual dysfunction
between patients with IBD and healthy persons.
However, our results are in agreement with other
studies in which no difference was observed in
sexual function scores between patients with IBD
and healthy controls, and where sexual dysfunction
was more often present only in patients with IBD
with an active disease [11,14,15]. In addition, it is
remarkable that no significant difference was
found in sexual desire scores between female
patients with active disease and controls, while
these patients had more often depressive symp-
toms than controls. An explanation could be that
desire problems are generally the most reported
sexual problem in women [44–46], and that
because of low desire scores in both patients and
controls, a floor effect hampered the observation
of significant differences among groups. It seems
that in the female patient population, active
disease had the strongest effect on lubrication and
pain. Possibly, complaints such as gas and diarrhea,
cause increased tension in the pelvic floor muscles,
which may result in pain during intercourse, and
possibly because of fear of pain, in lubrication
problems [47]. To examine the possible effect of
active disease on pelvic floor functioning and
sexual complaints, it will be interesting to include
a measure of pelvic floor hyperactivity in future
studies [48].
Another limitation of our study is that people
without a steady relationship were excluded from
participation, because not having a relationship
can influence the scores on the sexual function
questionnaires. The validated questionnaires that
were used are more suitable to people with stable
heterosexual relationships. Especially the FSFI,
where women who did not have intercourse in the
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last 4 weeks score very low, which will be seen as
sexual dysfunction. It is however possible that
there is a group of patients lacking a relationship
because of their sexual problems. In that case,
there could be an underestimation of sexual prob-
lems in the patient population. Also, the exclusion
of patients lacking a relationship may have resulted
in a relatively old study population, as younger
people are more often without a steady partner. It
could be that sexual problems play a bigger role in
young patients who just started to be sexually
active, and these patients may be underrepresented
in our study. In addition, it should be noted that
the IIEF, although presently the best validated and
most widely used questionnaire for male sexual
dysfunction, has a relative strong focus on erectile
function. It may be less suited to measure other
specific sexual dysfunctions, for example prema-
ture ejaculation. Therefore, it should be noted that
orgasmic problems in the male subjects may have
been detected less due to the use of the IIEF.
In conclusion, our data show that patients with
active IBD can experience depressive feelings and
that these are associated with sexual dysfunction.
Depressive feelings and an impaired sexual func-
tion have an important impact on quality of life. It
is important to ask patients about fatigue, mood,
and sexual function, and refer them for psycho-
logical or sex-therapeutic treatment when needed.
Corresponding Author: Stephanie Both, PhD, Out-
patient Clinic for Psychosomatic Gynaecology and Sex-
ology, Leiden University Medical Centre, Postbus
9600, Leiden 2300 RC, The Netherlands. Tel: (31)
71-526-8032; Fax: (31) 71-526-6950; E-mail: s.both@
lumc.nl




(a) Conception and Design
Stephanie Both; Andrea E. Van der Meulen-de
Jong; Moniek M. ter Kuile; Herma H. Fidder;
Helena E. de Groot; Linda G.J. Bel; Anna M.
Vollebregt
(b) Acquisition of Data
Linda G.J. Bel; Anna M. Vollebregt; Cornelia W.
Vliet-Vlieland; Willem R. Ten Hove; Andrea E.
Van der Meulen-de Jong
(c) Analysis and Interpretation of Data
Linda G.J. Bel; Anna M. Vollebregt; Stephanie
Both; Moniek M. ter Kuile; Andrea E. Van der
Meulen-de Jong
Category 2
(a) Drafting the Article
Linda G.J. Bel; Anna M. Vollebregt; Stephanie
Both; Moniek M. ter Kuile; Andrea E. Van der
Meulen-de Jong
(b) Revising It for Intellectual Content
Linda G.J. Bel; Anna M. Vollebregt; Stephanie
Both; Moniek M. ter Kuile; Andrea E. Van der
Meulen-de Jong; Herma H. Fidder; Helena E. de
Groot; Willem R. Ten Hove; Cornelia W.
Vliet-Vlieland
Category 3
(a) Final Approval of the Completed Article
Linda G.J. Bel; Anna M. Vollebregt; Stephanie
Both; Moniek M. ter Kuile; Andrea E. Van der
Meulen-de Jong; Herma H. Fidder; Helena E. de
Groot; Willem R. Ten Hove; Cornelia W.
Vliet-Vlieland
References
1 Baumgart DC, Sandborn WJ. Crohn’s disease. Lancet
2012;380:1590–605.
2 Ordas I, Eckmann L, Talamini M, Baumgart DC, Sandborn
WJ. Ulcerative colitis. Lancet 2012;380:1606–19.
3 Graff LA, Walker JR, Bernstein CN. Depression and anxiety
in inflammatory bowel disease: A review of comorbidity and
management. Inflamm Bowel Dis 2009;15:1105–18.
4 Angst J. Sexual problems in healthy and depressed persons. Int
Clin Psychopharmacol 1998;13(suppl 6):S1–4.
5 Basson R, Rees P, Wang R, Montejo AL, Incrocci L. Sexual
function in chronic illness. J Sex Med 2010;7(1 Pt 2):374–88.
6 Fabre LF, Smith LC. The effect of major depression on sexual
function in women. J Sex Med 2012;9:231–9.
7 Fabre LF, Clayton AH, Smith LC, Goldstein IM, Derogatis
LR. Association of major depression with sexual dysfunction in
men. J Neuropsychiatry Clin Neurosci 2013;25:308–18.
8 Laurent SM, Simons AD. Sexual dysfunction in depression and
anxiety: Conceptualizing sexual dysfunction as part of an inter-
nalizing dimension. Clin Psychol Rev 2009;29:573–85.
9 Clayton AH, Maserejian NN, Connor MK, Huang L, Heiman
JR, Rosen RC. Depression in premenopausal women with
HSDD: Baseline findings from the HSDD Registry for
Women. Psychosom Med 2012;74:305–11.
10 Muller KR, Prosser R, Bampton P, Mountifield R, Andrews
JM. Female gender and surgery impair relationships, body
image, and sexuality in inflammatory bowel disease: Patient
perceptions. Inflamm Bowel Dis 2010;16:657–63.
11 Timmer A, Bauer A, Kemptner D, Furst A, Rogler G. Deter-
minants of male sexual function in inflammatory bowel disease:
A survey-based cross-sectional analysis in 280 men. Inflamm
Bowel Dis 2007s;13:1236–43.
12 Moody G, Probert CS, Srivastava EM, Rhodes J, Mayberry JF.
Sexual dysfunction amongst women with Crohn’s disease: A
hidden problem. Digestion 1992;52:179–83.
13 Moody GA, Mayberry JF. Perceived sexual dysfunction
amongst patients with inflammatory bowel disease. Digestion
1993;54:256–60.
14 Timmer A, Kemptner D, Bauer A, Takses A, Ott C, Furst A.
Determinants of female sexual function in inflammatory bowel
disease: A survey based cross-sectional analysis. BMC
Gastroenterol 2008;8:45.
1566 Bel et al.
J Sex Med 2015;12:1557–1567
15 Timmer A, Bauer A, Dignass A, Rogler G. Sexual function in
persons with inflammatory bowel disease: A survey with
matched controls. Clin Gastroenterol Hepatol 2007;5:87–
94.
16 Lankeveld J, ter Kuile MM, Leuksink P. Seksuele disfuncties.
Diagnostiek en behandeling. Houten: Bohn Stafleu van
Loghum; 2010.
17 Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J,
Mishra A. The international index of erectile function (IIEF):
A multidimensional scale for assessment of erectile dysfunc-
tion. Urology 1997;49:822–30.
18 Hendren SK, O’Connor BI, Liu M, Asano T, Cohen Z,
Swallow CJ, Macrae HM, Gryfe R, McLeod RS. Prevalence of
male and female sexual dysfunction is high following surgery
for rectal cancer. Ann Surg 2005;242:212–23.
19 Cappelleri JC, Rosen RC, Smith MD, Mishra A, Osterloh IH.
Diagnostic evaluation of the erectile function domain of the
International Index of Erectile Function. Urology 1999;54:
346–51.
20 Rosen R, Brown C, Heiman J, Leiblum S, Meston C, Shabsigh
R, Ferguson D, D’Agostino R Jr. The Female Sexual Function
Index (FSFI): A multidimensional self-report instrument for
the assessment of female sexual function. J Sex Marital Ther
2000;26:191–208.
21 ter Kuile MM, Brauer M, Laan E. The Female Sexual Func-
tion Index (FSFI) and the Female Sexual Distress Scale
(FSDS): Psychometric properties within a Dutch population. J
Sex Marital Ther 2006;32:289–304.
22 Wiegel M, Meston C, Rosen R. The Female Sexual Function
Index (FSFI): Cross-validation and development of clinical
cutoff scores. J Sex Marital Ther 2005;31:1–20.
23 Zigmond AS, Snaith RP. The Hospital Anxiety and Depres-
sion Scale. Acta Psychiatr Scand 1983;67:361–70.
24 Spinhoven P, Ormel J, Sloekers PP, Kempen GI, Speckens
AE, Van Hemert AM. A validation study of the Hospital
Anxiety and Depression Scale (HADS) in different groups of
Dutch subjects. Psychol Med 1997;27:363–70.
25 Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity
of the Hospital Anxiety and Depression Scale. An updated
literature review. J Psychosom Res 2002;52:69–77.
26 Irvine EJ, Zhou Q, Thompson AK. The Short Inflammatory
Bowel Disease Questionnaire: A quality of life instrument for
community physicians managing inflammatory bowel disease.
CCRPT Investigators. Canadian Crohn’s Relapse Prevention
Trial. Am J Gastroenterol 1996;91:1571–8.
27 Han SW, Gregory W, Nylander D, Tanner A, Trewby P,
Barton R, Welfare M. The SIBDQ: Further validation in
ulcerative colitis patients. Am J Gastroenterol 2000;95:145–51.
28 Walmsley RS, Ayres RC, Pounder RE, Allan RN. A simple
clinical colitis activity index. Gut 1998;43:29–32.
29 Harvey RF, Bradshaw JM. A simple index of Crohn’s disease
activity. Lancet 1980;1:514.
30 Best WR. Predicting the Crohn’s disease activity index from
the Harvey–Bradshaw Index. Inflamm Bowel Dis 2006;12:
304–10.
31 Jowett SL, Seal CJ, Phillips E, Gregory W, Barton JR, Welfare
MR. Defining relapse of ulcerative colitis using a symptom-
based activity index. Scand J Gastroenterol 2003;38:164–71.
32 Tinsley A, Macklin EA, Korzenik JR, Sands BE. Validation of
the Functional Assessment of Chronic Illness Therapy—
Fatigue (FACIT-F) in patients with inflammatory bowel
disease. Aliment Pharmacol Ther 2011;34:1328–36.
33 Hagelin CL, Wengstrom Y, Runesdotter S, Furst CJ. The
psychometric properties of the Swedish Multidimensional
Fatigue Inventory MFI-20 in four different populations. Acta
Oncol 2007;46:97–104.
34 Smets EM, Garssen B, Bonke B, De Haes JC. The Multidi-
mensional Fatigue Inventory (MFI) psychometric qualities of
an instrument to assess fatigue. J Psychosom Res 1995;39:315–
25.
35 Minderhoud IM, Oldenburg B, van Dam PS, van
Berge Henegouwen GP. High prevalence of fatigue in quies-
cent inflammatory bowel disease is not related to adrenocorti-
cal insufficiency. Am J Gastroenterol 2003;98:1088–93.
36 Sprangers MA, te Velde A, Aaronson NK. The construction
and testing of the EORTC Colorectal Cancer-Specific Quality
of Life Questionnaire module (QLQ-CR38). European Orga-
nization for Research and Treatment of Cancer Study Group
on Quality of Life. Eur J Cancer 1999;35:238–47.
37 Baron RM, Kenny DA. The moderator–mediator variable dis-
tinction in social psychological research: Conceptual, strategic,
and statistical considerations. J Pers Soc Psychol 1986;51:
1173–82.
38 MacKinnon DP, Lockwood CM, Hoffman JM, West SG,
Sheets V. A comparison of methods to test mediation and other
intervening variable effects. Psychol Methods 2002;7:83–
104.
39 Preacher KJ, Hayes AF. Asymptotic and resampling strategies
for assessing and comparing indirect effects in multiple media-
tor models. Behav Res Methods 2008;40:879–91.
40 Schouffoer AA, van der Marel J, Ter Kuile MM, Weijenborg
PT, Voskuyl A, Vliet Vlieland CW, van Laar JM,
Vliet Vlieland TP. Impaired sexual function in women with
systemic sclerosis: A cross-sectional study. Arthritis Rheum
2009 ;61:1601–8.
41 ter Kuile MM, Weijenborg PT, Spinhoven P. Sexual function-
ing in women with chronic pelvic pain: The role of anxiety and
depression. J Sex Med 2010;7:1901–10.
42 Jelsness-Jorgensen LP, Bernklev T, Henriksen M, Torp R,
Moum BA. Chronic fatigue is more prevalent in patients with
inflammatory bowel disease than in healthy controls. Inflamm
Bowel Dis 2011;17:1564–72.
43 Yilmaz H, Yilmaz SD, Polat HA, Salli A, Erkin G, Ugurlu H.
The effects of fibromyalgia syndrome on female sexuality: A
controlled study. J Sex Med 2012;9:779–85.
44 West SL, D’Aloisio AA, Agans RP, Kalsbeek WD, Borisov
NN, Thorp JM. Prevalence of low sexual desire and
hypoactive sexual desire disorder in a nationally representative
sample of US women. Arch Intern Med 2008;168:1441–9.
45 Witting K, Santtila P, Varjonen M, Jern P, Johansson A, von
der Pahlen B, Sandnabba K. Female sexual dysfunction, sexual
distress, and compatibility with partner. J Sex Med 2008;
5:2587–99.
46 Shifren JL, Monz BU, Russo PA, Segreti A, Johannes CB.
Sexual problems and distress in United States women: Preva-
lence and correlates. Obstet Gynecol 2008;112:970–8.
47 Brauer M, ter Kuile MM, Janssen SA, Laan E. The effect of
pain-related fear on sexual arousal in women with superficial
dyspareunia. Eur J Pain 2007;11:788–98.
48 Voorham-van der Zalm PJ, Berzuk K, Shelly B, Kamin B,
Putter H, Lycklama À Nijeholt GA, Pelger RC, Stiggelbout
AM. Validation of the Pelvic Floor Inventories Leiden (PelFIs)
in English. Neurourol Urodyn 2011;30:536–40.
Sexual Dysfunction in IBD Patients 1567
J Sex Med 2015;12:1557–1567
